Interestingly, we did not find any statistical significance between PRSS23 expression and tumor invasion (p = 0.56) or PRSS23 and HER-2 overexpression, which suggests that HER-2 amplification may not affect PRSS23 expression (p = 0.79). The gene discussed is ERBB2; the disease is neoplasm.